• About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • MS Symptoms
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • MS Symptoms
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
NEWS
RESOURCES
PODCAST
  • NEWS
  • RESOURCES
  • PODCAST
  • VIDEOS
  • CONTACT
Donate
Subscribe
Search
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • MS Symptoms
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • MS Symptoms
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
 The relationship between optic neuritis and remyelination
By support
In
Posted 3 January 2011

The relationship between optic neuritis and remyelination

Prof Stuart Graham

0
Read More
 Development of a new class of therapeutics for the treatment of MS
By support
In
Posted 3 January 2011

Development of a new class of therapeutics for the treatment of MS

Prof Shaun McColl

0
Read More
 How are the supporting cells damaged in MS?
By support
In
Posted 2 January 2011

How are the supporting cells damaged in MS?

Biyi Chen

0
Read More
 BDNF protein’s influence on myelination in the brain and spinal cord
By support
In
Posted 1 January 2011

BDNF protein’s influence on myelination in the brain and spinal cord

Agnes Wong

0
Read More
 Proteomics of MS
By support
In
Posted 6 January 2010

Proteomics of MS

Professor Shaun McColl Professor Claude Bernard Prof Bill Carroll Dr Judith Greer Dr Peter Hoffmann Professor Ian Smith

0
Read More
 Abnormal venous drainage of the CNS in MS
By support
In
Posted 6 January 2010

Abnormal venous drainage of the CNS in MS

Associate Professor Brian Chambers, Austin Hospital Ms Heather Cameron, Austin Health Ms Jayne Chambers, Austin Health Professor Richard Macdonell, Austin Health

0
Read More
 Understanding mechanisms of brain and spinal damage in MS
By support
In
Posted 6 January 2010

Understanding mechanisms of brain and spinal damage in MS

Professor Helmut Butzkueven, Florey Neuroscience Institutes

0
Read More
 Working out why lesions occur where they do in MS
By support
In
Posted 6 January 2010

Working out why lesions occur where they do in MS

Dr Judith Greer Professor Michael Pender

0
Read More
 Understanding the events that control myelination in the CNS
By support
In
Posted 6 January 2010

Understanding the events that control myelination in the CNS

Dr Ben Emery

0
Read More
 Identifying what causes an MS lesion
By support
In
Posted 5 January 2010

Identifying what causes an MS lesion

Dr John Parratt

0
Read More
1 2 3 4 5 6 7 8 9 ...
page 1 of 16
MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

  • MS Clinical Trials
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
Facebook-f X-twitter Linkedin-in Youtube Instagram Spotify Paper-plane

Quick links

  • What is MS?
  • How is MS diagnosed?
  • COVID-19 and MS
  • Research funding opportunities
  • Research we fund
  • Media enquiries
  • Contact us
© 2026 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

The relationship between optic neuritis and remyelination